Evidence map›Paper›PMID 41805592›Full record

ArticleJCI insight2026

Macrophage ferritin heavy chain/α-synuclein regulatory axis modulates ferroptosis during kidney injury.

Tanima Chatterjee, Sarah Machado, Kellen Cowen, Mary E Miller, Bronte Johnson, Yanfeng Zhang, Laura A Volpicelli-Daley, Lauren A Fielding, Rudradip Pattanayak, Frida Rosenblum and 5 more

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tanima ChatterjeeDivision of Nephrology, Department of Medicine.
Sarah MachadoDivision of Nephrology, Department of Medicine.
Kellen CowenDivision of Nephrology, Department of Medicine.
Mary E MillerDivision of Nephrology, Department of Medicine.
Bronte JohnsonDivision of Nephrology, Department of Medicine.
Yanfeng ZhangDepartment of Genetics.
Laura A Volpicelli-DaleyCenter for Neurodegeneration and Experimental Therapeutics, Department of Neurology, and.
Lauren A FieldingCenter for Neurodegeneration and Experimental Therapeutics, Department of Neurology, and.
Rudradip PattanayakCenter for Neurodegeneration and Experimental Therapeutics, Department of Neurology, and.
Frida RosenblumDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
László PotorHUN-REN-UD Vascular Pathophysiology Research Group 11003, Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
György BallaHUN-REN-UD Vascular Pathophysiology Research Group 11003, Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Jozsef BallaHUN-REN-UD Vascular Pathophysiology Research Group 11003, Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Christian FaulDivision of Nephrology, Department of Medicine.
Abolfazl ZarjouDivision of Nephrology, Department of Medicine.

Funding

Regulation of Macrophage Phenotype by Ferritin Heavy Chain in CKDR01DK134402 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Abolfazl Zarjou · 2023 to 2026
$1.6M
NIDDK NIH HHS R01 DK134402
6 · The paper itself

Abstract

Macrophages, endowed with remarkable phenotypic plasticity, are essential for orchestrating injury responses and regulating iron homeostasis. Given the central role of ferritin heavy chain (FtH) as a molecular rheostat linking iron sequestration to redox-dependent signaling, we examined how myeloid FtH governs renal iron trafficking and ensuing oxidative stress pathways during acute kidney injury (AKI). Transcriptome analysis revealed coupling of FtH deficiency in monocytes and macrophages with activation of ferroptosis, a regulated cell death associated with iron accumulation. Moreover, myeloid FtH deletion worsened AKI, increasing leukocyte infiltration and iron deposition, together with ferroptosis-associated gene induction, oxidative stress, and lipid peroxidation. Notably, α-synuclein (SNCA), an iron-binding protein and the main pathological driver of Parkinson's disease, was robustly induced both by FtH deficiency and following AKI. Mechanistic studies showed that monomeric SNCA exhibits ferrireductase activity, amplifying redox cycling and promoting ferroptotic cell death. Furthermore, SNCA expression was elevated in kidney pathologies characterized by leukocyte expansion in both mouse models and human cohorts, suggesting that inflammatory microenvironments promote SNCA accumulation and redox imbalance. These findings define a macrophage FtH/SNCA regulatory axis as a key driver of ferroptosis in AKI, implicating SNCA as a pathological nexus between iron dyshomeostasis and inflammatory kidney injury.

Indexed as

Acute Kidney Injuryalpha-SynucleinApoferritinsFerroptosisMacrophagesAnimalsDisease Models, AnimalHumansIronKidneyMaleMiceMice, KnockoutOxidative Stressalpha-SynucleinApoferritinsIronCell stressChronic kidney diseaseImmunologyMacrophagesNephrology

Identifiers

PMID41805592
PMCPMC13135404

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.